共 46 条
[1]
Levy DE(2006)STAT3: a multifaceted oncogene Proc Natl Acad Sci USA 103 10151-10152
[2]
Inghirami G(2007)Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome Nature 448 1058-1062
[3]
Minegishi Y(2012)Somatic STAT3 mutations in large granular lymphocytic leukemia N Engl J Med 366 1905-1913
[4]
Saito M(2012)STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia Blood 120 3048-3057
[5]
Tsuchiya S(2003)Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma Clin Cancer Res 9 3692-3699
[6]
Tsuge I(2001)Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells Leukemia 15 787-793
[7]
Takada H(2011)Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies Leukemia 25 1439-1443
[8]
Hara T(2005)Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target Nat Med 11 623-629
[9]
Koskela HL(2005)Targeting Stat3 in cancer therapy Anticancer Drugs 16 601-607
[10]
Eldfors S(undefined)undefined undefined undefined undefined-undefined